CD274 and non-small cell lung carcinoma: Although a positive correlation between PD-L1 expression and treatment outcomes has been observed in advanced stage NSCLC patients [1, 5–7], a considerable proportion (60% to 70%) of patients with PD-L1 positive tumors do not respond [1, 2, 5].